Tiorfan


Indications and Reactions:

Role Indications Reactions
Secondary
Prophylaxis 17.8%
Product Used For Unknown Indication 12.5%
Pyrexia 10.4%
Diarrhoea 8.2%
Hypertension 5.3%
Drug Use For Unknown Indication 5.1%
Ill-defined Disorder 4.4%
Pain 4.2%
Cord Blood Transplant Therapy 3.8%
Cytomegalovirus Infection 3.6%
Anxiety 3.2%
Insomnia 3.2%
Cholestasis 3.0%
Immunosuppression 3.0%
Hypothyroidism 2.5%
Acute Myeloid Leukaemia 2.3%
Vitamin B12 Deficiency 2.3%
Gastroenteritis 1.9%
Candida Infection 1.7%
Nausea 1.7%
Thrombotic Microangiopathy 27.9%
Hemiplegia 9.3%
Pyrexia 7.0%
Acute Generalised Exanthematous Pustulosis 4.7%
Macrocytosis 4.7%
Malaise 4.7%
Off Label Use 4.7%
Subileus 4.7%
Toxic Epidermal Necrolysis 4.7%
Toxic Skin Eruption 4.7%
Abnormal Behaviour 2.3%
Coagulopathy 2.3%
Cytolytic Hepatitis 2.3%
Diarrhoea Infectious 2.3%
Erythema Infectiosum 2.3%
Erythema Multiforme 2.3%
Faecaloma 2.3%
Grand Mal Convulsion 2.3%
Haematotoxicity 2.3%
Hepatocellular Damage 2.3%
Concomitant
Product Used For Unknown Indication 38.3%
Diarrhoea 9.7%
Drug Use For Unknown Indication 8.9%
Hiv Infection 5.5%
Hypertension 4.6%
Prophylaxis 3.9%
Bone Marrow Transplant 2.9%
Multiple Myeloma 2.9%
Angina Pectoris 2.5%
Crohn's Disease 2.5%
Mitochondrial Toxicity 2.5%
Pain 2.1%
Her-2 Positive Breast Cancer 1.9%
Nausea 1.9%
Pain Prophylaxis 1.9%
Acute Myelomonocytic Leukaemia 1.7%
Diabetes Mellitus 1.7%
Hepatic Cirrhosis 1.7%
Oral Candidiasis 1.7%
Anxiety 1.6%
Thrombocytopenia 11.2%
Vomiting 10.4%
Renal Failure Acute 8.8%
Toxic Epidermal Necrolysis 8.8%
Agranulocytosis 6.4%
Weight Decreased 5.6%
Pancreatic Insufficiency 4.8%
Renal Failure 4.8%
Septic Shock 4.8%
Thrombotic Microangiopathy 4.8%
Toxoplasmosis 4.0%
Weight Increased 4.0%
Cholestasis 3.2%
Normochromic Normocytic Anaemia 3.2%
Sepsis 3.2%
Ascites 2.4%
Asthenia 2.4%
Drug Interaction 2.4%
General Physical Health Deterioration 2.4%
Ileus 2.4%

Drug Data